Digital health technology in use
INDUSTRY

Digital Health & HealthTech

The part of healthcare where software is the product. Companies here move at technology speed and are judged by healthcare rules — clinical safety, privacy law, interoperability mandates and reimbursement pathways that were written for a different kind of organisation. This page covers how the sector is structured and where the pressure points sit.

Discuss Your Use Case
THE SECTOR TODAY

What Defines Digital Health

Digital health companies build software under healthcare rules. Clinical safety, privacy, interoperability and reimbursement determine whether a product can be adopted.

Three structural features shape everything:

The Buyer Is Rarely The User.

A clinician uses the product, a health system pays for it, a patient experiences it, and a payer decides whether any of it is reimbursed. Four parties, four sets of criteria, and a sales cycle that reflects all of them.

Regulatory Status Is A Product Decision, Not A Legal One.

Whether a product is a regulated medical device or a wellness tool is determined by intended purpose and claims — the words on the marketing site as much as the code. That line is drawn during product definition, and moving it later is expensive.

Integration Is The Gate.

A product that cannot read from and write to the systems a health system already runs is a parallel workflow, and parallel workflows are abandoned. Interoperability determines adoption more reliably than feature depth.

HOW COMPANIES ARE STRUCTURED

The Shapes Companies Take In This Sector

Point Solutions

A single clinical or operational problem solved well — remote monitoring for one condition, scheduling, prior authorisation, documentation. Fast to sell, hard to defend, and under constant pressure to widen scope before the core is stable.

Virtual Care And Telehealth

Care delivered remotely, which makes the company a provider organisation as well as a technology one — clinician licensing, credentialing, malpractice cover, prescribing rules and state or national scope-of-practice limits all become operating concerns.

Clinical Decision Support And Diagnostics

Software that interprets data and suggests or produces a clinical finding. This is where the regulated-device line is most often crossed, and where evidence expectations are highest.

Patient Engagement And Digital Therapeutics

Products where the intervention itself is software — behaviour change programmes, symptom management, adherence. Digital therapeutics carry clinical evidence obligations closer to pharmaceutical products than to consumer apps.

Infrastructure And Data Platforms

Interoperability layers, data pipelines, identity, consent management and analytics sold to other healthcare organisations rather than to clinicians directly.

Provider And Payer Operations

Revenue cycle, claims, care management, utilisation review, network operations. Less visible, larger budgets, longer contracts.

Companies frequently move between these. A point solution that adds clinical interpretation crosses into device regulation. A patient engagement product that adds licensed clinicians becomes a provider. The regulatory and operational consequences of those moves are usually discovered after the fact.

THE REGULATORY FRAME

The Rules That Determine What You Can Build And Claim

HIPAA

US, protected health information

Safeguards, access control, audit logging, breach notification, and Business Associate Agreements with every partner touching PHI

FDA device regulation / SaMD

US, software with a medical purpose

Whether the product requires clearance, what evidence supports the claims, and how future versions may change

FDA enforcement discretion

US, lower-risk health software

Categories of wellness and low-risk software the agency has indicated it does not actively regulate — a position, not an exemption

EU MDR

EU, medical device software

Classification, conformity assessment, clinical evaluation and post-market obligations for software with a medical purpose

21st Century Cures Act — information blocking

US

Prohibitions on practices that interfere with access, exchange or use of electronic health information

ONC certification & API rules

US

Standardised FHIR-based API access to health data, shaping how third-party products connect to certified EHRs

TEFCA

US

A framework for nationwide health information exchange between networks

GDPR

EU/UK

Lawful basis, consent, minimisation, cross-border transfer and data subject rights over health data

SOC 2 Type II

Global, commercial

Not law, but the de facto security requirement to close an enterprise health system or payer contract

State licensure & prescribing rules

US

Where clinicians may practise, what they may prescribe, and under what remote-care conditions

CPT codes for RPM/RTM

US reimbursement

Whether a service can be billed, by whom, and under what documentation and time thresholds

The practical consequence: regulatory status, security posture and interoperability approach are architectural decisions taken at the start. All three are significantly more expensive to retrofit than to design in.

WHERE THE DATA LIVES

The Systems A Product Has To Reach

Electronic Health Records

The clinical system of record. Access is via standards-based APIs where available, and via interface engines and flat-file exchange where it is not. Each health system's configuration differs.

Practice Management And Scheduling

Appointments, eligibility, encounter administration. Frequently a separate vendor to the EHR.

Claims And Revenue Cycle

Eligibility checks, prior authorisation, claim submission and remittance, running on transaction standards that predate modern APIs.

Pharmacy Systems

E-prescribing networks, formulary and benefit checks, medication history.

Devices And Wearables

Consumer and clinical device data arriving through vendor SDKs, aggregators or platform health frameworks.

Identity And Consent

Patient matching, provider directories, authentication, and records of what a patient has agreed to.

Analytics And Data Platforms

The warehouse layer where population, quality and outcome reporting is produced.

WHAT'S CHANGING

Six Shifts Reshaping The Sector

01

Pilot-To-Contract Is The Hard Part Now

Health systems have run pilots for a decade. The scarce outcome is a signed enterprise contract with a budget line and an owner.

02

API Access To Health Data Became A Mandate, Not A Favour

Regulation requiring standardised API access changed the negotiating position for third-party products, though real-world variation between deployments remains substantial.

03

The Device Line Moved Under AI Features

Adding interpretation, prediction or triage to a product that previously only displayed data can move it into regulated territory.

04

Evidence Expectations Rose

Buyers increasingly ask for outcome data rather than usage data. Evidence generation has to be planned into the product rather than assembled for a sales cycle.

05

Reimbursement Pathways Matured Unevenly

Billing codes exist for remote monitoring and some digital services, which makes certain business models viable.

06

Security Review Became The Long Pole

Enterprise health customers run vendor risk assessments that assume a mature security programme. Companies without documented controls lose deals at a stage where the product was never the issue.

COMMON FRICTION POINTS

Where Teams In This Sector Get Stuck

Regulatory Status Decided Too Late.

Claims written for marketing that move the product across the device line, discovered during a customer's legal review.

Integration Scoped As A Feature.

Treated as one sprint, when each health system deployment carries its own configuration, credentialing timeline and data quirks.

Compliance Retrofitted Before A Deal.

Audit logging, access control and data segregation added under deal pressure rather than designed in, at several times the cost.

Clinical Workflow Ignored.

A product that requires clinicians to leave their existing system to use it, competing against a workflow that already works well enough.

Evidence Assembled Reactively.

Outcome data pulled together when a buyer asks, from instrumentation never designed to answer that question.

Scaling On A Prototype Architecture.

The build that won the pilot carrying production load, PHI and enterprise security expectations it was never designed for.

BUILD WITH CONFIDENCE

Build Your Next Digital Health Platform

Nirmitee Health builds clinical, data and integration software for digital health and healthtech companies. Healthcare is the only industry we serve.